SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy

Limited data exist regarding the immune benefits of fourth COVID-19 vaccine doses in people with HIV (PWH) receiving antiretroviral therapy (ART), particularly now that most have experienced a SARS-CoV-2 infection. We quantified wild-type, Omicron-BA.5 and Omicron-BQ.1-specific neutralization up to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Peter K., Lapointe, Hope R., Sang, Yurou, Ennis, Siobhan, Mwimanzi, Francis, Speckmaier, Sarah, Barad, Evan, Dong, Winnie, Liang, Richard, Simons, Janet, Lowe, Christopher F., Romney, Marc G., Brumme, Chanson J., Niikura, Masahiro, Brockman, Mark A., Brumme, Zabrina L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Fast Track
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994812/
https://www.ncbi.nlm.nih.gov/pubmed/36789806
http://dx.doi.org/10.1097/QAD.0000000000003519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994812/
https://www.ncbi.nlm.nih.gov/pubmed/36789806
http://dx.doi.org/10.1097/QAD.0000000000003519

Ejemplares similares